Fig. 8
From: OCTN2- and ATB0,+-targeted nanoemulsions for improving ocular drug delivery
In vivo anti-inflammatory efficacy of DEX 10% SC-NEs in a rabbit model of EIU. A Slit-lamp observation of clinical symptoms (e.g., iris hyperaemia, exudation); (B) H&E sections of the iris-ciliary body from different groups and black arrow indicated inflammatory cell infiltration (bar = 50 μm); (C) Relative mRNA levels of MCP-1, MMP-1, and VCAM-1 in iris-ciliary body from different groups (n = 3). *P < 0.05